These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 407553

  • 1. [Immunological deficiency in various disorders of lymphoreticular system].
    Frydecka I.
    Pol Tyg Lek; 1977 May 30; 32(22):851-3. PubMed ID: 407553
    [No Abstract] [Full Text] [Related]

  • 2. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP, Fernandes B.
    Schweiz Med Wochenschr; 1975 Sep 13; 105(37):1174-9. PubMed ID: 814616
    [Abstract] [Full Text] [Related]

  • 3. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I, Diumenjo M.
    Rev Clin Esp; 1977 Mar 31; 144(6):403-9. PubMed ID: 140441
    [No Abstract] [Full Text] [Related]

  • 4. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F, Lacava V, Fiorilli M, Ciarla MV.
    Acta Haematol; 1973 Mar 31; 50(5):275-83. PubMed ID: 4202631
    [No Abstract] [Full Text] [Related]

  • 5. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E.
    Rinsho Ketsueki; 1976 Jun 31; 17(6):600-17. PubMed ID: 823349
    [No Abstract] [Full Text] [Related]

  • 6. [Immunological behavior of patients with malignant blood diseases].
    Luca N.
    Stud Cercet Med Interna; 1973 Jun 31; 14(5):429-46. PubMed ID: 4202394
    [No Abstract] [Full Text] [Related]

  • 7. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S, Gociu M.
    Stud Cercet Med Interna; 1969 Jun 31; 10(3):197-208. PubMed ID: 4186583
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. T and B cells in clinical disorders.
    Tomasi TB, Stobo JD.
    Dis Mon; 1977 Feb 31; 23(5):1-55. PubMed ID: 401725
    [No Abstract] [Full Text] [Related]

  • 16. Malignant disease of the lymphoid system in immunological perspective.
    Hansen JA, Good RA.
    Hum Pathol; 1974 Sep 31; 5(5):567-99. PubMed ID: 4137052
    [No Abstract] [Full Text] [Related]

  • 17. [Membrane markers in chronic lymphoproliferative diseases].
    Matutes E, San Miguel JF, Catovsky D.
    Med Clin (Barc); 1983 Mar 05; 80(7):334-50. PubMed ID: 6406774
    [No Abstract] [Full Text] [Related]

  • 18. [New concepts in the classification of malignant hemopathies].
    Rappaport H.
    Bull Cancer; 1974 Mar 05; 61(1):11-22. PubMed ID: 4218497
    [No Abstract] [Full Text] [Related]

  • 19. Blastic transformation of lymphocytes in some proliferative diseases of the leukocytic system.
    Szewczyk Z, Kopaczynska K.
    Arch Immunol Ther Exp (Warsz); 1971 Mar 05; 19(6):781-7. PubMed ID: 5004016
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.